Issue Price
₹40
Per Share
GMP
NIL
Grey Market
Est. Listing
₹40
Expected Price
Min. Application
₹240,000
2 lots × 3000 shares
Incorporated in 2021, Sangani Hospitals Limited is a healthcare organization. They embarked on their journey in 2001 with the establishment of Sangani Hospital in Keshod. Sangani Hospitals is a multi-specialty healthcare provider operating in the Keshod and Veraval regions of Gujarat.Sangani Hospitals is promoted by Dr. Ajaykumar Natwarlal Sangani, MBBS, DLO & MS(E.N.T.), and his brother Dr. Rajeshkumar Natwarlal Sangani, MBBS & MD. They have been in the medical practice for nearly two decades.The organization offers its specialty in a variety of departments and unit, including-ENT Department, OBST-Gynec Department, Dialysis unit, Orthopedic Department, Joint Replacement, General Surgery Department, Urosurgery, Trauma unit, Dental Surgery Department, Physiotherapy unit, laparoscopic surgery, and so on.Sangani Hospitals at present offers its specialty services and other support services out of two hospitals i.e. Sangani Hospital at Keshod, Junagadh, Gujarat and Sangani Super Speciality Hospital, Veraval, Gujarat.
Sangani Hospitals Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
| Category | Shares Offered | % Issue | Amount (₹ Cr)* | Subscription |
|---|---|---|---|---|
| Market Maker | 192,000 | — | ₹0.77 Cr | — |
| TOTAL | 3,792,000 | 100.00% | ₹15.17 Cr | — |
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 3,000 | ₹120,000 |
| Retail (Max) | 13 | 39,000 | ₹1,560,000 |
| sNII (Min) | 14 | 42,000 | ₹1,680,000 |
| bNII (Min) | 68 | 204,000 | ₹8,160,000 |
| Particulars | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|
| Revenue from Operations | 1576.24 | 420.63 | 498.21 |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | 148.37 | 105.35 | 79.06 |
| Net Worth | 1797.29 | 501.60 | 168.79 |
| Total Assets | 1959.01 | 705.45 | 299.20 |
| Reserves & Surplus | 798.79 | 106.78 | 168.83 |
| Total Borrowings | 34.57 | N/A | 10.08 |